FDA Adverse Event Injury Summary report: N

BIOTENE ORAL BALANCE GEL (AROMA)

MDR report key: 5541029 · Received April 1, 2016

Report

Report Number
1718912-2016-00013
Event Type
Injury
Date Received
April 1, 2016
Report Date
March 23, 2016
Manufacturer
ULTRADENT PRODUCTS INC./ ORATECH LLC
Product Code
LFD
PMA / PMN Number
K123731
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

REPORT 1718912-2016-00013 IS ASSOCIATED WITH ARGUS CASE (B)(4) BIOTENE ORAL BALANCE GEL (AROMA).

Description of Event or Problem · 1

ASPIRATED SOME BIOTENE GEL [MEDICATION ASPIRATION], RESPIRATORY COMPLICATION ASSOCIATED WITH DEVICE [RESPIRATORY COMPLICATION ASSOCIATE WITH DEVICE]. CASE DESCRIPTION: THIS CASE WAS REPORTED BY A CONSUMER AND DESCRIBED THE OCCURRENCE OF MEDICATION ASPIRATION IN A (B)(6) MALE PATIENT WHO RECEIVED GLUCOSE OXIDASE (BIOTENE ORAL BALANCE GEL (AROMA)) GEL (BATCH NUMBER W4N081, EXPIRY DATE 30TH NOVEMBER 2017) FOR PRODUCT USED FOR UNKNOWN INDICATION. ON AN UNKNOWN DATE, THE PATIENT STARTED BIOTENE ORAL BALANCE GEL (AROMA) AT AN UNKNOWN DOSE AND FREQUENCY. ON AN UNKNOWN DATE, AN UNKNOWN TIME AFTER STARTING BIOTENE ORAL BALANCE GEL (AROMA), THE PATIENT EXPERIENCED MEDICATION ASPIRATION (SERIOUS CRITERIA GSK MEDICALLY SIGNIFICANT) AND RESPIRATORY COMPLICATION ASSOCIATED WITH DEVICE. BIOTENE ORAL BALANCE GEL (AROMA) WAS DISCONTINUED (DECHALLENGE WAS POSITIVE). ON AN UNKNOWN DATE, THE OUTCOME OF THE MEDICATION ASPIRATION WAS RECOVERED/RESOLVED AND THE OUTCOME OF THE RESPIRATORY COMPLICATION ASSOCIATED WITH DEVICE WAS UNKNOWN. IT WAS UNKNOWN IF THE REPORTER CONSIDERED THE MEDICATION ASPIRATION AND RESPIRATORY COMPLICATION ASSOCIATED WITH DEVICE TO BE RELATED TO BIOTENE ORAL BALANCE GEL (AROMA). ADDITIONAL DETAILS, THE CONSUMER STATED THAT HE ASPIRATED SOME BIOTENE GEL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
196424 BIOTENE ORAL BALANCE GEL (AROMA) ORAL GEL LFD ULTRADENT PRODUCTS INC./ ORATECH LLC W4N081

Patients

Seq Age Sex Outcome Treatment
1 69 YR Other